The increasing demand for monoclonal antibodies (MAbs) as biopharmaceuticals has promoted the development of cell cultures with increased expression levels. As a consequence, the demand for more efficient purification processes has increased.
Capto™ adhere is a multimodal BioProcess™ medium designed for post-protein A purification of monoclonal antibodies (MAbs). Capto adhere can remove key contaminants such as DNA, host cell proteins (HCP), leached protein A, dimers and larger aggregates, and viruses in a single step, allowing the design of a two-step process together with MabSelect SuRe™.
Capto adhere offers:
| |
